These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 29344173)
1. RASAL1 inhibits HepG2 cell growth via HIF-2α mediated gluconeogenesis. Meng F; Zhang W; Wang Y Oncol Lett; 2017 Dec; 14(6):7344-7352. PubMed ID: 29344173 [TBL] [Abstract][Full Text] [Related]
2. RAS protein activator-like 1 is functionally involved in hypoxia resistance in breast cancer cells by targeting hypoxia inducible factor-1α. Huang Z; Wang R; Wei G; Jiang R; Zheng Y; Tian Y; Chen B; Ye C; Xue M; Yu C Oncol Lett; 2017 Sep; 14(3):3839-3845. PubMed ID: 28927155 [TBL] [Abstract][Full Text] [Related]
3. RASAL1 attenuates gastric carcinogenesis in nude mice by blocking RAS/ERK signaling. Chen H; Zhao JY; Qian XC; Cheng ZY; Liu Y; Wang Z Asian Pac J Cancer Prev; 2015; 16(3):1077-82. PubMed ID: 25735335 [TBL] [Abstract][Full Text] [Related]
4. Enforced expression of RASAL1 suppresses cell proliferation and the transformation ability of gastric cancer cells. Qiao F; Su X; Qiu X; Qian D; Peng X; Chen H; Zhao Z; Fan H Oncol Rep; 2012 Oct; 28(4):1475-81. PubMed ID: 22825043 [TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA TUC338 is functionally involved in sorafenib-sensitized hepatocarcinoma cells by targeting RASAL1. Jin W; Chen L; Cai X; Zhang Y; Zhang J; Ma D; Cai X; Fu T; Yu Z; Yu F; Chen G Oncol Rep; 2017 Jan; 37(1):273-280. PubMed ID: 27878301 [TBL] [Abstract][Full Text] [Related]
6. Decreased expression of the RAS-GTPase activating protein RASAL1 is associated with colorectal tumor progression. Ohta M; Seto M; Ijichi H; Miyabayashi K; Kudo Y; Mohri D; Asaoka Y; Tada M; Tanaka Y; Ikenoue T; Kanai F; Kawabe T; Omata M Gastroenterology; 2009 Jan; 136(1):206-16. PubMed ID: 18992247 [TBL] [Abstract][Full Text] [Related]
7. Reduced expression of RAS protein activator like-1 in gastric cancer. Seto M; Ohta M; Ikenoue T; Sugimoto T; Asaoka Y; Tada M; Mohri D; Kudo Y; Ijichi H; Tateishi K; Otsuka M; Hirata Y; Maeda S; Koike K; Omata M Int J Cancer; 2011 Mar; 128(6):1293-302. PubMed ID: 20473946 [TBL] [Abstract][Full Text] [Related]
8. Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells. Zhao D; Zhai B; He C; Tan G; Jiang X; Pan S; Dong X; Wei Z; Ma L; Qiao H; Jiang H; Sun X Cell Signal; 2014 May; 26(5):1030-9. PubMed ID: 24486412 [TBL] [Abstract][Full Text] [Related]
9. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway. Blancher C; Moore JW; Robertson N; Harris AL Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776 [TBL] [Abstract][Full Text] [Related]
10. Hypoxia inducible factor 1α and hypoxia inducible factor 2α play distinct and functionally overlapping roles in oral squamous cell carcinoma. Zhu GQ; Tang YL; Li L; Zheng M; Jiang J; Li XY; Chen SX; Liang XH Clin Cancer Res; 2010 Oct; 16(19):4732-41. PubMed ID: 20807755 [TBL] [Abstract][Full Text] [Related]
11. RASAL1 induces to downregulate the SCD1, leading to suppression of cell proliferation in colon cancer via LXRα/SREBP1c pathway. Wang G; Li Z; Li X; Zhang C; Peng L Biol Res; 2019 Dec; 52(1):60. PubMed ID: 31847887 [TBL] [Abstract][Full Text] [Related]
12. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway. Carroll VA; Ashcroft M Cancer Res; 2006 Jun; 66(12):6264-70. PubMed ID: 16778202 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of RASAL1 Indicates Poor Prognosis and Promotes Invasion of Ovarian Cancer. Chang RX; Cui AL; Dong L; Guan SP; Jiang LY; Miao CX Open Life Sci; 2019 Jan; 14():133-140. PubMed ID: 33817145 [TBL] [Abstract][Full Text] [Related]
14. [Silencing hypoxia inducible factor-2α gene by small interference RNA inhibits the growth of mammosphere cells in nude mice under hypoxic microenvironment]. Qu HB; Fan YM; Han ML; Zeng N; Zhu ZK; Liu H; Xie J; Wu CY; Tang WX Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(15):1182-7. PubMed ID: 23902893 [TBL] [Abstract][Full Text] [Related]
15. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720 [TBL] [Abstract][Full Text] [Related]
16. Hypoxia induces dysregulation of lipid metabolism in HepG2 cells via activation of HIF-2α. Cao R; Zhao X; Li S; Zhou H; Chen W; Ren L; Zhou X; Zhang H; Shi R Cell Physiol Biochem; 2014; 34(5):1427-41. PubMed ID: 25323790 [TBL] [Abstract][Full Text] [Related]
17. Hypoxia-induced, perinecrotic expression of endothelial Per-ARNT-Sim domain protein-1/hypoxia-inducible factor-2alpha correlates with tumor progression, vascularization, and focal macrophage infiltration in bladder cancer. Onita T; Ji PG; Xuan JW; Sakai H; Kanetake H; Maxwell PH; Fong GH; Gabril MY; Moussa M; Chin JL Clin Cancer Res; 2002 Feb; 8(2):471-80. PubMed ID: 11839666 [TBL] [Abstract][Full Text] [Related]
18. HIF-2α regulates CD44 to promote cancer stem cell activation in triple-negative breast cancer Bai J; Chen WB; Zhang XY; Kang XN; Jin LJ; Zhang H; Wang ZY World J Stem Cells; 2020 Jan; 12(1):87-99. PubMed ID: 32110277 [TBL] [Abstract][Full Text] [Related]
19. Metformin Enhances the Effect of Regorafenib and Inhibits Recurrence and Metastasis of Hepatic Carcinoma After Liver Resection via Regulating Expression of Hypoxia Inducible Factors 2α (HIF-2α) and 30 kDa HIV Tat-Interacting Protein (TIP30). Yang Q; Guo X; Yang L Med Sci Monit; 2018 Apr; 24():2225-2234. PubMed ID: 29654226 [TBL] [Abstract][Full Text] [Related]
20. miR-130b-5p promotes proliferation, migration and invasion of gastric cancer cells via targeting RASAL1. Chen H; Yang Y; Wang J; Shen D; Zhao J; Yu Q Oncol Lett; 2018 May; 15(5):6361-6367. PubMed ID: 29731849 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]